Patterns of relapse as determined by 68 Ga-PSMA ligand PET/CT after radical prostatectomy

ConclusionOur results suggest that in patients with biochemical recurrence who did not receive early sRT, a68Ga-PSMA ligand PET/CT for restaging of disease allows for tailoring and individualizing treatment. Particularly in patients with PSA levels above 1.0  ng/mL, a68Ga-PSMA ligand PET/CT should be performed for therapy planning, since patients often have metastases not confined to the pelvis.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research